1Assistant Professor, Department of Veterinary Medicine, Veterinary College Karnatka Veterinary, Animal and Fisheries Sciences University (KVAFSU), Hebbal, Bengaluru – 560024, Karnataka
2Dean, Veterinary College Karnatka Veterinary, Animal and Fisheries Sciences University (KVAFSU), Hebbal, Bengaluru – 560024, Karnataka
3Department of Veterinary Surgery and Radiology, Veterinary College Karnatka Veterinary, Animal and Fisheries Sciences University (KVAFSU), Hebbal, Bengaluru – 560024, Karnataka
4Department of Veterinary Pathology, Veterinary College Karnatka Veterinary, Animal and Fisheries Sciences University (KVAFSU), Hebbal, Bengaluru – 560024, Karnataka
Department of Veterinary Medicine, Veterinary College Karnatka Veterinary, Animal and Fisheries Sciences University (KVAFSU), Hebbal, Bengaluru – 560024, Karnataka
*Corresponding author. E-mail: deeptibr@rediffmail.com
Online published on 2 August, 2016.
The study was undertaken to evaluate the effectiveness of Pimobendan in the management of congestive heart failure (CHF) in dogs. CHF was diagnosed by history, physical examination, hematology, blood biochemistry, electrocardiography and echocardiography. Twelve dogs were randomly allotted to two treatment groups I and II. Group I underwent treatment with conventional drugs like Frusemide, Spironolactone, Enalapril with or without Digoxin and Group II animals along with conventional treatment were administered Pimobendan. Monitoring of the animals over a period of 2 months indicated that Pimobendan was beneficial in the management of CHF.
Congestive heart failure, dog, pimodendan
